Aβ1-14-εK-HBsAg3 Th links an Aβ(1-14) motif to an HBsAg3 T-helper sequence via ε-lysine conjugation. Researchers use it to investigate antigen presentation, epitope exposure, and aggregation behavior. The hybrid construct provides defined structural transitions in solution. Applications include immunogenicity-model research and peptide-aggregation studies.
CAT No: R2852
Aβ1-14-εK-HBsAg3 Th is a synthetic peptide chimera that integrates the N-terminal sequence of amyloid beta (Aβ1-14) with an ε-lysine (εK) linker and a triple repeat of the hepatitis B surface antigen (HBsAg3 Th) T helper epitope. This engineered construct is designed to facilitate advanced immunological and neurodegenerative disease research, leveraging the immunogenic properties of HBsAg3 Th and the pathobiological relevance of the Aβ1-14 fragment. By combining these distinct peptide motifs, the molecule enables the study of antigenic presentation, epitope mapping, and immune system interactions within the context of amyloidogenic pathways and viral antigenicity. Its modular nature makes it a valuable tool for dissecting the interplay between immune recognition and peptide aggregation, with significant implications for fundamental and translational research.
Immunogenicity assessment: Researchers utilize this chimeric peptide to evaluate T cell responses to defined epitopes, particularly in the context of vaccine design and immune profiling. The inclusion of the HBsAg3 Th helper T cell epitope enhances the immunogenic potential of the construct, allowing for precise analysis of helper T cell activation in response to the Aβ1-14 sequence. Such studies are instrumental in elucidating the mechanisms underlying antigen-specific immune responses, supporting the rational development of immunotherapeutic strategies and peptide-based vaccines.
Epitope mapping: The construct serves as a critical reagent for mapping B cell and T cell epitopes within hybrid peptide sequences. By presenting both amyloid beta and HBsAg-derived motifs in a single molecule, it facilitates the characterization of cross-reactive or dominant epitopes recognized by immune cells or antibodies. This application is particularly relevant for researchers seeking to define the minimal immune-stimulatory regions within complex antigens, thereby informing the design of targeted immunogens or diagnostic assays.
Peptide aggregation studies: The Aβ1-14 segment of the chimera provides a model system for investigating the aggregation behavior of amyloidogenic peptides, a process central to the pathology of neurodegenerative disorders such as Alzheimer's disease. When conjugated to immunogenic epitopes, the aggregation kinetics and structural transitions of the peptide can be monitored under various in vitro conditions. Findings from such experiments contribute to a deeper understanding of how immunological modifications influence peptide aggregation and stability, offering insights into disease mechanisms and potential intervention points.
Antigen processing research: The hybrid peptide is employed to study the processing and presentation of multi-epitope antigens by antigen-presenting cells (APCs). Its modular structure allows for the dissection of proteolytic cleavage patterns, peptide-MHC complex formation, and subsequent T cell activation. These investigations are pivotal for advancing knowledge of antigen processing pathways, particularly in the context of complex or chimeric antigens, and for optimizing peptide constructs intended for immunotherapeutic applications.
Analytical method development: Laboratories leverage the defined sequence and immunogenic features of this peptide to calibrate and validate analytical techniques such as ELISA, flow cytometry, and mass spectrometry. Its unique combination of amyloidogenic and viral epitopes provides a robust standard for assessing assay sensitivity, specificity, and reproducibility when detecting multi-epitope antigens. This utility supports the development of reliable research tools for both basic and applied immunology, ensuring high-quality data generation in experimental workflows.
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More